Cargando…
Exploring the mechanism of YangXue QingNao Wan based on network pharmacology in the treatment of Alzheimer’s disease
It is clinical reported that YangXue QingNao Wan (YXQNW) combined with donepezil can significantly improve the cognitive function of AD patients. However, the mechanism is not clear. A network pharmacology approach was employed to predict the protein targets and affected pathways of YXQNW in the tre...
Autores principales: | Zhang, Yuying, Guo, Kaimin, Zhang, Pengfei, Zhang, Mengying, Li, Xiaoqiang, Zhou, Shuiping, Sun, He, Wang, Wenjia, Wang, Hui, Hu, Yunhui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465410/ https://www.ncbi.nlm.nih.gov/pubmed/36105078 http://dx.doi.org/10.3389/fgene.2022.942203 |
Ejemplares similares
-
YangXue QingNao Wan, a Compound Chinese Medicine, Attenuates Cerebrovascular Hyperpermeability and Neuron Injury in Spontaneously Hypertensive Rat: Effect and Mechanism
por: Jiao, Ying-Qian, et al.
Publicado: (2019) -
YangXue QingNao Wan and Silibinin Capsules, the Two Chinese Medicines, Attenuate Cognitive Impairment in Aged LDLR (+/-) Golden Syrian Hamsters Involving Protection of Blood Brain Barrier
por: Gu, You-Yu, et al.
Publicado: (2018) -
Therapeutic effect of Yang-Xue-Qing-Nao granules on sleep dysfunction in Parkinson’s disease
por: Pan, Weidong, et al.
Publicado: (2013) -
A meta‐analysis of the effectiveness of Yangxue Qingnao granules for the treatment of chronic cerebral circulation insufficiency
por: Jia, Yujuan, et al.
Publicado: (2020) -
Efficacy and safety of Yangxue Qingnao granules for the treatment of essential hypertension: A protocol for systematic review and meta-analysis
por: Liu, Yongcheng, et al.
Publicado: (2021)